Skip to content

Dr FS Oft

Active
Private limited companyfounded 20232 yrs activePaul Delvauxwijk 29, 3000 Leuven, BelgiumKBO/BCE: BE 1001.121.657

Dr FS Oft has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €443k and a net result of €219k. Equity is growing by ~96.1% per year across the filed fiscal years. Its solvency ranks better than 77% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
95 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record82
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days only on tighter terms
Liquidity ample (current ratio 7.02 against 4.23 in 2024; short-term debt: 14.2% and cash: 32% of total assets), and 14.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 2 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
85.8%
Return on assets
42.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-02-2026, 156 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
156 d early
2024
11 d early
2023
1 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€443k▲ 97.9%
2024 · €224k
2023: €13k 2024: €224k
2023 → 2025
Total assets
€516k▲ 76.3%
2024 · €293k
2023: €18k 2024: €293k
2023 → 2025
Net result
€219k▲ 3.7%
2024 · €211k
2023: €10k 2024: €211k
2023 → 2025
Working capital
€442k▲ 98.4%
2024 · €223k
2023: €11k 2024: €223k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€13k-€224k▲ 1,673%€443k▲ 97.9%
Operating result€12k-€276k▲ 2,186%€286k▲ 3.9%
Net result€10k-€211k▲ 2,095%€219k▲ 3.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2023: €12k€12kNet result 2023: €10k€10kOperating result 2024: €276k€276kNet result 2024: €211k€211kOperating result 2025: €286k€286kNet result 2025: €219k€219k202320242025
The operating result has risen two years in a row; 2025 is 4% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €516k
Fixed assets €1k▲ 1.8%
Current assets €515k▲ 76.6%
Equity and liabilities €516k
Equity €443k▲ 97.9%
Debt €73k▲ 6.4%
The debt ratio falls from 23.5% to 14.2%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€287k
2024 · €276k
Cash flow
€220k
2024 · €212k
Solvency
85.8%
2024 · 76.5%
Current ratio
7.02
2024 · 4.23
Quick ratio
7.02
2024 · 4.23
Debt / equity
0.17
2024 · 0.31
ROE
49.5%
2024 · 94.4%
ROA
42.4%
2024 · 72.1%
Interest coverage
549.76
2024 · 809.75
Debt
€73k
2024 · €69k
Debt ≤ 1 year
€73k
2024 · €69k
Income taxes
€68k
2024 · €65k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€293k€516k
Fixed assets21/28€1k€1k
Tangible fixed assets22/27€1k€1k
Plant, machinery and equipment23€392€229
Furniture and vehicles24€728€911
Current assets29/58€292k€515k
Amounts receivable within one year40/41€16k€18k
Other amounts receivable41€16k€18k
Current investments50/53-€300k
Cash at bank and in hand54/58€256k€165k
Deferred charges and accrued income490/1€19k€32k
Equity and liabilities
Total equity and liabilities10/49€293k€516k
Equity10/15€224k€443k
Contributions10/11€3k€3k=
Profit (loss) carried forward14€221k€440k
Amounts payable17/49€69k€73k
Amounts payable within one year42/48€69k€73k
Financial debts43€359€1k
Credit institutions430/8€359€1k
Trade debts44€3k€3k
Suppliers440/4€3k€3k
Taxes, remuneration and social security45€66k€69k
Taxes450/3€66k€69k
Other amounts payable47/48€0-
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€506€700
Other operating charges640/8€325€269
Gross operating margin9900€276k€287k
Operating profit (loss)9901€276k€286k
Financial income75/76B€509€951
Recurring financial income75€509€951
Financial charges65/66B€341€522
Recurring financial charges65€341€522
Profit (loss) for the period before taxes9903€276k€287k
Income taxes67/77€65k€68k
Profit (loss) for the period9904€211k€219k
Profit (loss) for the period to be appropriated9905€211k€219k
Appropriation of the result
Profit (loss) to be appropriated9906€221k€440k
Profit (loss) brought forward from the previous period14P€10k€221k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
25-02
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2023net €219k ▲3.7%
Operating result €286k, net result €219k, both a record.
20-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Equity above €200kEq €224k ▲1673%
2 profitable years in a row build equity to €224k.
30-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2023
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Paul Delvauxwijk 293000 Leuven
Ground area
45 m²
Building footprint
30 m²
Volume, LiDAR
241 m³
Parcel 24505F0199/00A005, Flanders · tallest building 10.2 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Dr FS Oft
Paul Delvauxwijk 29, 3000 LeuvenSpecialist medical practice
since 20232.351.657.805
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24505F0199/00A005 Flanders 45 m² 1 · 30 m² 10.2 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 6,508 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded12-10-2023
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.